[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP0832278A1 - Amplification lineaire liee d'acides nucleiques - Google Patents

Amplification lineaire liee d'acides nucleiques

Info

Publication number
EP0832278A1
EP0832278A1 EP96919362A EP96919362A EP0832278A1 EP 0832278 A1 EP0832278 A1 EP 0832278A1 EP 96919362 A EP96919362 A EP 96919362A EP 96919362 A EP96919362 A EP 96919362A EP 0832278 A1 EP0832278 A1 EP 0832278A1
Authority
EP
European Patent Office
Prior art keywords
primers
primer extension
primer
nucleic acid
generation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96919362A
Other languages
German (de)
English (en)
Other versions
EP0832278A4 (fr
Inventor
Robert Bruce Wallace
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Laboratories Inc
Original Assignee
Bio Rad Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories Inc filed Critical Bio Rad Laboratories Inc
Publication of EP0832278A1 publication Critical patent/EP0832278A1/fr
Publication of EP0832278A4 publication Critical patent/EP0832278A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]

Definitions

  • the present invention relates to the in vitro replication of nucleic acids. More specifically, the invention relates to a process for replicating a nucleic acid sequence of interest, with large quantities of the desired sequence ultimately resulting from the linkage of primer extension reactions wherein the sequence of interest accumulates in a mathematically linear fashion.
  • nucleic acid "amplification” finds wide utility, both practical and theoretical, in a variety of contexts.
  • H.G. Khorana and his co-workers first proposed the use of an in vitro DNA amplification process to increase available amounts of double-stranded DNA (partial sequences of the gene for the major yeast alanine t-RNA) that had been created by the enzymatic ligation of synthetic DNA's. See K. Kleppe et al. ; J. Mol. Biol. 56:341-361 (1971) . Later, in . vitro amplification was applied to the amplification of genomic DNA (Saiki et al.
  • PCR polymerase chain reaction
  • PCR has proven to be a valuable technique for the molecular biologist, and has been used extensively in the fields of human genetic research, diagnostics and forensic science, and even in the detection of antibodies, disadvantages nevertheless have been recognized.
  • the PCR process can be difficult to quantify accurately, mainly because the amplification products increase exponentially with each round of amplification.
  • the products of PCR namely, double-stranded DNA molecules, are difficult to analyze or sequence per se. Strand separation typically must be carried out prior to sequencing or other downstream processes that requires single stranded nucleic acids, such as hybridization to a probe capable of detecting the sequence of interest.
  • the PCR process also has proven to be quite susceptible to contamination generated through the transfer of previously amplified DNA sequences into a new reaction. This problem appears to be caused by the facts that (1) very large amounts of DNA are generated in any given reaction cycle and (2) the process uses all product DNA strands as templates in subsequent cycles. Even minute quantities -• " contaminating DNA can be exponentially amplified and lead to erroneous results. See Kwok and Higuchi, Nature 3_3_9_:237-238
  • nucleic acid (DNA) amplification methods that provide large amounts of DNA, and that selectively amplify only a specific sequence of interest, but which avoid the problems now associated with the "PCR" reaction.
  • nucleic acid amplification methods that ultimately produce large amounts of a nucleic acid molecule of interest, or large amounts of a molecule containing a nucleic acid sequence of interest, but are relatively insensitive to the presence of contaminating nucleic acids.
  • nucleic acid amplification methods that generate single-stranded products.
  • the present invention provides a process for amplifying a specific nucleic acid sequence of interest within complementary nucleic acid strands contained in a sample, the process including the steps of: (a) contacting the strands with a primer that contains a non-replicable element, under conditions such that first generation primer extension product - are synthesized using said strands as templates, and wherein the primer for a strand is selected such that a first generation primer extension product synthesized thereon, when separated from the strand, can serve as a template for synthesis of a second generation primer extension product of the primer for the complement of the strand;
  • step (c) treating the first generation primer extension products with the primers of step (a) under conditions such that second generation primer extension products are synthesized using the first generation primer extension products as templates; wherein the second generation primer extension products contain at least a portion of the nucleic acid sequence of interest and cannot serve as templates for the synthesis of extension products of the primers which were extended to synthesize their templates.
  • step (c) the products of step (c) are separated to produce single-stranded molecules, and the entire process is repeated at least once.
  • Step (c) preferably is repeated many times, with the process being carried out in an automated fashion under the control of a programmable thermal cycling apparatus.
  • a new set of primers that contain non-replicable elements can be employed.
  • the new set of primers advantageously bind to the second generation synthetic products, bounding the sequence of interest to be amplified.
  • the linear replication process is again carried out through a number of cycles. Such "linking together" of multi ⁇ cycle primer extension reactions ultimately results in thousand-fold or million-fold amplification of the original nucleic acid sequence of interest. Thus, the present process is deemed “linked linear amplification" or "LLA.”
  • multiple (nested) sets of primers containing non-replicable elements can be provided in a single amplification reaction mixture.
  • the sets are selected so as to be capable of binding to their respective templates under decreasingly stringent conditions.
  • all the components necessary to carry out several linked linear amplifications can be provided in a single reaction mixture.
  • allele-specific nucleic acid replication is carried out according to the present invention with the use of primers directed to specific polymorphic sites on the template that are known to be indicative of a genetic disease or disorder, such as sickle cell disease.
  • the allele-specific primers, containing non-replicable elements, are designed so that they prime nucleic acid synthesis of only those templates containing the desired allele.
  • the synthetic nucleic acid molecules resulting from the present process can be used in the diagnosis of genetic disorders or diseases, as reagents in further techniques such as gene cloning, for forensic identification, etc.
  • the process described r. rcin also can be carried out using a single nucleic acid strand as a starting material.
  • Such a process comprises:
  • Steps (a) - (c) can be repeated many times, resulting in extensive nucleic acid synthesis, following which the reaction is linked to a subsequent reaction using a new set of primers.
  • This process comprises:
  • Steps (a) - (d) can be repeated many times, resulting in extensive nucleic acid synthesis, following which the reaction may be linked to a subsequent reaction using a new set of primers.
  • the second primer may optionally contain a cleavable element such that the linked linear amplification reaction can be carried out on either a double-stranded cr a single-stranded starting template.
  • the present invention also relates to a reagent kit for use in amplifying a particular nucleic acid sequence.
  • kit includes, for example, a DNA polymerase, two or more primers for each sequence to be amplified wherein each of said primers comprises a non- replicable element or incorporates a cleavable element, and, optionally, a control nucleic acid sequence capable of being replicated by the primers and DNA polymerase.
  • the kit also may contain a nucleic acid probe capable of indicating the presence or absence of an amplification product of the particular sequence. Where the kit contains primers incorporating a cleavable element, it may also contain reagents for cleaving the primer at the cleavable element.
  • Figures 1 - 4 comprise a schematic representation of a nucleic acid amplification process of the present invention.
  • Figures 5 - 6 comprise a schematic representation of a nucleic acid amplification process that has been linked to the process represented by Figures 1 - 4.
  • Figure 7 is a more detailed schematic representation of a nucleic acid amplification process carried out with two primers according to the present invention.
  • Figures 8 - 10 present a detailed schematic representation of a linked linear nucleic acid amplification process carried out with four primers according to the present invention.
  • Figure 11 is a schematic representation of nucleic acid molecules prepared by the PCR process and by a process according to the present invention.
  • Figure 12 is a schematic representation of the sequence of the human -globin gene (GenBank locus HUMHBB) and of several primers described herein.
  • Figure 13 is the sequence of Human Growth Hormone Sequence amplified in Example 7. The relative positions of the oligonucleotides used in the experiment are underlined. Oligonucleotide GH1 hybridizes to the complement of the Human Growth Hormone sequence shown. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • the process in its preferred form comprises a linked series of multi-cycle primer extension reactions.
  • primer-dependent nucleic acid replication is carried out through a number of cycles, with the primer extension products accumulating in a numerically linear fashion from cycle to cycle.
  • a unique primer, or set of primers is provided for each nucleic acid strand in the starting sample that contains the sequence to be amplified.
  • the linear accumulation of primer extension products from cycle to cycle is assured through the use of primers that contain non-replicable elements -- elements that halt the primer extension reaction, preventing the nucleic acid polymerase from replicating the entire sequence of the primer.
  • the linear accumulation of the desired primer extension products is assured through the use of primers that contain cleavable elements, where cleavage of the first primer extension product results in a second primer extension product lacking the functional binding site for the first primer.
  • primers that contain cleavable elements, where cleavage of the first primer extension product results in a second primer extension product lacking the functional binding site for the first primer.
  • second generation primer extension products the primer extension products which accumulate in greatest abundance
  • the process of the present invention utilizes and takes advantage of a number of important properties of oligonucleotide hybridization and the primer extension reaction.
  • the invention takes advantage of the facts that:
  • DNA polymerase is able to copy a template DNA many times by sequential cycles of denaturation and primer-dependent elongation.
  • Primer-dependent elongation can occur, under appropriate conditions, even if the primer is not completely complementary to the template.
  • Primer extension can utilize a template produced in a previous round of primer extension.
  • Primer extension is inhibited by abasic sites or by non-nucleotide residues when such are present in the template nucleic acid.
  • primer extension may be inhibited by physically removing a portion of the generation primer extension product by cleaving this molecule at the cleavable sites incorporated into the primers used in the primer extension reaction.
  • Primer length and composition affect, in known ways, the conditions (e.g., temperature) at which a primer will "prime” polymerase-induced extension on a template.
  • Primer extension reactions can be performed in rapid cycles with the aid of thermal cycling apparatus.
  • the present process advantageously utilizes a series of linear amplification reactions, which can be carried out (linked) either in series or in parallel (i.e., simultaneously) to generate a very large number of copies of a nucleic acid sequence of interest.
  • the nucleic acid sequence of interest may encompass essentially the entire length of the template t and(s) , or it may comprise only a very minor portion of it.
  • the template strand(s) containing the sequence of interest may be present in a substantially homogeneous sample or as part (even an extremely minor part) of a mixture of nucleic acids.
  • a primer that contains a non-replicable or cleavable element is provided for each strand containing a sequence to be amplified.
  • the primer(s) are added either prior to or following denaturation of the template.
  • the primers are permitted to anneal to their respective starting templates, and are extended in the presence of a polymerase enzyme, under conditions appropriate for the function of the enzyme, to form first generation primer extension products.
  • the process is repeated by denaturing the resulting duplexed nucleic acid, permitting the primers to anneal to the strands and again carrying out the primer extension reaction.
  • FIGS 1 - 5 present a schematic representation of one series of primer extension reactions (i.e., one linear amplificatio.. ⁇ action) carried out on a DNA template according to the process of the present invention. The process is illustrated starting in step (a) with a double-stranded DNA molecule having defined termini. The strands of the starting DNA are denoted by solid ( ) lines throughout Figures 1 - 4.
  • the starting duplex is denatured, preferably by heating in a buffer solution containing the same, and the resulting single strands are contacted with a pair of primers (step (b) ) .
  • Each primer preferably is provided in substantial molar excess of the starting template strand and contains within its sequence a non- replicable or alternatively, a cleavable element, here denoted by (x) or (o) within the primer sequence.
  • the primers anneal to their respective templates and are elongated (step (c) ) according to the primer extension reaction in the presence of a DNA polymerase and the four deoxyribonucleotides.
  • Synthesized DNA is denoted by dotted (••••••) lines in Figures 1 - 4, and the DNA synthesized using the starting duplex DNA as a template is denoted "first generation" DNA.
  • the resulting templates again are denatured, and the primers are annealed (step (d) ) .
  • step (e) of Figure 2 primer elongation using first generation DNA as a template results in the preparation of second generation DNA and does not progress past the non-replicable element incorporated into the first generation synthetic DNA.
  • second generation molecules accumulate in a mathematically linear fashion in subsequent rounds of primer extension.
  • the synthetic DNA is utilized as a starting material for (i.e., linked to) a second series of primer extension reactions using a second set of primers.
  • primers containing non-replicable elements designated (a) and (b) are selected so as to be able to utilize molecules 10 and 20, the products of the reaction of Figures 1 - 4, as templates for further DNA synthesis.
  • This series of primer extension reactions similarly results in the accumulation of synthetic DNA molecules, designated by reference numerals 30 and 40 in step (e) of Figure 6, which cannot serve as templates for the primers utilized in those reactions.
  • these synthetic molecules can be linked to further replication using appropriate primers again containing non-replicable or cleavable elements.
  • the first primer extension reaction is followed by a reaction in which the first primer extension product is cleaved at the position of the cleavable element, prior to the second primer extension reaction.
  • the synthetic nucleic acid products of any one series of cycles can themselves serve as templates for further amplification only if a new primer or set of primers is provided.
  • a first linear amplification is performed for one hundred cycles, the one hundred copies produced from this reaction can be used as a template in a linked linear amplification (LLA) reaction using a new set of primers capable of hybridizing to the synthetic templates.
  • LLA linked linear amplification
  • One hundred additional cycles of linear amplification provides a cumulative amplification of ten thousand (100*100) .
  • Repeating the process with a third set of primers yields a cumulative amplification of lxlO 6 . Additional amplification is achieved through the use of additional primers and additional cycles of primer extension.
  • Figure 7 schematically illustrates, in greater detail, the use of two primers in an amplification process according to the present invention.
  • two primers are utilized for sequential rounds of primer extension.
  • Each primer is complementary to the target sequence but contains a single non-replicable element (X) in place of one of the complementary nucleotides.
  • reaction 1 primer PI produces copies (first generation nucleic acid; product I) of the upper strand of the template. One copy of product I is produced during each cycle, m cycles leading to m copies.
  • reaction 2 primer P2 similarly produces copies (first generation nucleic acid; product II) of the lower strand of the template. One copy of product II is produced during each cycle, n cycles leading to n copies. In practice, n and m typically are the same.
  • primer PI produces copies (second generation nucleic acid; product III) of product II (designated template II) from reaction 2, except that template II is not replicated beyond the non-replicable element incorporated therein.
  • product III is not a template foi ° it. ⁇ er primer PI or P2.
  • primer P2 produces 5 copies (second generation nucleic acid; product IV) of template I, except that template I is not replicated beyond the non-replicable element.
  • product IV is not a template for either primer PI or P2.
  • Table 1 shows the accumulation of each product as 10 a function of cycle number. As can be seen, the equation (n 2 +n) /2 can be used to calculate the yield of the reaction. If the efficiency of the reaction is less than 100%, amplification will be less.
  • a third primer containing a non-replicable element and complementary to either product III or product IV is included in the reaction, a new product, shorter than either product III or product IV will accumulate. This product will be in greater abundance than any other DNA strand in the reaction and will remain mostly single stranded.
  • Four primers are used in this reaction, thereby linking two two-primer reactions that are simultaneously carried out.
  • primers PI and P3 are complementary to the upper strand of the target nucleic acid and P2 and P4 are complementary to the lower strand.
  • the complementary site for primer P3 is 5' (with respect to the template) of the PI complementary site.
  • the complementary site for primer P4 is 5' (with respect to the template) of the P2 complementary site.
  • the nucleic acid sequence of interest advantageously will be located within the region bounded by both primer pairs.
  • reactions IA, IB, 2A and 2B each result in the linear accumulation of first generation synthetic nucleic acid (products IA, IB, IIA and IIB, respectively) complementary to a respective strand of the starting nucleic acid template.
  • reactions 3A, 3B, 4A and 4B each result in the linear accumulation of second generation synthetic nucleic acid which, due to the presence of the non-replicable element in the nucleic acid synthesized in reactions IA, IB, 2A and 2B, does not serve as a template for primer PI or P2.
  • primers P3 and P4 due to the location of their complementary site, can function to prime DNA synthesis on both original template DNA and templates IVA and IIIA, respectively.
  • Products IIIB and IVB are not templates for any primers of this reaction, but contain the nuclei- acid sequence of interest. It will be apparent that variations to the reactions described herein will be possible.
  • the linear amplification reactions can be sequentially linked, rather than being carried out simultaneously as described in connection with Figures 8 - 10.
  • primers P3 and P4 can be added to the reaction mixture following n cycles of primer extension, where n ranges, for example, from 2 to 100.
  • primers PI and P2 are selected so that they are capable of annealing to the template DNA and priming DNA synthesis under conditions (e.g., temperature) that do not permit primers P3 and P4 to prime.
  • Primers PI, P2, P3 and P4 will be provided in the initial reaction mixture.
  • the first linear amplification is carried out under the more stringent conditions, where only primers PI and P2 participate in primer extension. Following a desired number of cycles, the reaction conditions are made less stringent, whereupon all four primers participate in nucleic acid synthesis.
  • Primers PI and P2 continue to generate first generation primer extension products using the starting template and second generation primer extension products using the first generation products as template; primers P3 and P4 also utilize second generation primer extension products of primers PI and P2 as templates.
  • the nucleic acid sequence of interest advantageously is located within the region of the template strand bounded by both primer pairs. If a fifth primer containing a non-replicable element and complementary to either product IIIB or product IVZ ⁇ included in the reaction, a new product, shorter than either IIIB or IVB, will accumulate. This product will be in greater abundance than any other DNA strand in the reaction and will remain mostly single stranded. Those skilled in the field of molecular biology will realize that whenever an odd number of primers is utilized to practice this invention, an accumulation of single stranded DNA will result.
  • primers that contain non-replicable and/or cleavable elements ensures that, except for primer extension products synthesized on an original template nucleic acid strand present in the starting material (such primer extension products being referred to herein as "first generation primer extension products") , none of the synthetic nucleic acids produced during the process will serve as templates in subsequent rounds of primer extension.
  • first generation primer extension products such primer extension products being referred to herein as "first generation primer extension products”
  • primers that contain a residue of 1, 3-propanediol can be synthesized according to the method described in Seela et al. , Nucleic Acids Res. 15, 3113-3129 (1987) and are commercially available from Glen Research, 44901 Falcon Place, Sterling, VA, 20166 USA.
  • Primers containing a residue of 1,4-anhydro-2-deoxy-D-ribitol, the model for the abasic site can be synthesized with the assistance of Eritja et al .
  • the non-replicable element preferably is not located at the terminal residue of any of the primers.
  • primers containing ribonucleosides can be routinely synthesized by those of skill in nucleic acid chemistry using standard methods of oligonucleotide synthesis by incorporating protected ribonucleotide in place of deoxyribonucleotides in oligonucleotide synthesis reactions known to those of skill in nucleic acid chemistry.
  • Appropriate ribonucleoside containing primers are commercially available.
  • One method of cleaving first primer extension products utilizes the difference in reactivity of phosphodiester bonds adjacent to a ribonucleoside compared with the reactivity of phosphodiester bonds adjacent to deoxyribonucleosides.
  • Primer extension products containing ribonucleotides can be easily cleaved by treating the products with a ribonuclease (RNase) , such as RNase A. If uridine triphosphate (UTP) is incorporated into the primer, the enzyme uracil N-glycosylase (UNG) can also be used to cleave the first primer extension product to remove its complementary primer hybridization site.
  • RNase ribonuclease
  • UTP uridine triphosphate
  • UNG uracil N-glycosylase
  • primer extension products containing ribonucleosides can be cleaved by treating the products with hydroxide, preferably 0.5 N NaOH.
  • Preferred primers will contain one or more ribonucleosides which will be located at a position in the primer so that cleavage will disrupt the hybridization site for one of the primers used in the subsequent primer extension reaction.
  • the ribonucleoside can be located at the 3' terminus of the primer since, unlike the non-replicable element, it will not interfere with the DNA polymerase mediated extension reaction.
  • a typical amplification reaction will be carried out starting with a double- stranded DNA molecule that contains a sequence to be replicated embedded within a much longer sequence.
  • An oligonucleotide primer specific for each of the strands is annealed to its respective strand, with each primer containing a non-replicable and/or cleavable element as described herein.
  • the primers are selected so that they bind to the respective strands at positions bounding the sequence to be amplified.
  • a first cycle of primer extension is carried out in the presence of a DNA polymerase and the four deoxyribonucleotide bases, under conditions appropriate for the selected enzyme.
  • the resulting first generation synthetic DNA will have incorporated therein the oligonucleotide primer at its 3' end and the entire binding site for the other primer downstream (5') therefrom.
  • the primer contains a cleavable element
  • the resulting first generation synthetic DNA will have incorporated therein the oligonucleotide primer containing the cleavable element or elements at its 3' end.
  • first generation synthetic DNA serves as a template for the other primer, that is, the primer which is not incorporated at its 3' end.
  • DNA synthesis progresses along the template, but halts when the non- replicable element embedded in the template is encountered by the polymerase molecule.
  • the resulting synthetic DNA herein termed "second generation synthetic DNA,” has discrete ends defined at its 5' end by the entire sequence of its primer, and defined at its 3' end by only a portion of the sequence of the other primer -- the portion that was copied by the DNA polymerase prior to encountering the non-replicable element.
  • Second generation synthetic DNA will not participate as a template for further DNA synthesis .
  • second generation synthetic DNA contains only a portion of the necessary primer binding site. Under the selected primer annealing and extension conditions, that portion of the primer binding site is insufficient to permit the primer to bind and serve as a site for primer-dependent DNA synthesis. Thus, when the third and subsequent cycles of primer extension are carried out, only original template DNA and first generation synthetic DNA participate as templates. The continued copying of those templates results in the round-to-round "linear" accumulation of second generation synthetic DNA containing the sequence of interest.
  • additional replication can be attained by providing a second primer for each strand, the second primer (s) being selected so as to bind to regions of the original template strands within the region bounded by the original set of primers.
  • the second primers will contain non-replicable and/or cleavable elements, thereby ensuring that their primer extension products cannot serve as templates for nucleic acid synthesis in subsequent rounds using those same primers.
  • the first primer extension products made using these primers will cleaved at the position of the cleavable elements, such that second primer extension products produced from the first will not contain a functional binding site from which new copies identical to the first strand primer can be generated.
  • primer binding conditions can dictate whether a specific primer will bind to a specific template. See Rychlik et al. , Nucleic Acids Res. 18, 6409-6412 (1990) ; Wu et al., DNA Cell Biol. 10, 233-238 (1991) .
  • the selection of a primer binding temperature can also function to select which primers will be capable of priming DNA synthesis.
  • first, second and third sets of primers that will prime at 72°, 62° and 52° C, respectively, in a single amplification reaction mixture
  • carrying out a first series of primer extension reactions at 72° C will ensure that only the first primer set will function to bring about primer- dependent nucleic acid synthesis.
  • the primer extension temperature can be lowered to 62° C, whereupon the first and second primer sets will prime DNA synthesis.
  • Lowering the primer extension reaction temperature to 52° C permits all three primer sets to participate in primer- dependent DNA synthesis.
  • the use of mixtures of primers in the present process permits the process to be carried out in an efficient manner, without the need for the researcher separately to add each primer set as the process progresses.
  • all three primer sets as described above can be provided in a single amplification reaction mixture.
  • the primers will be selected so that those that prime DNA synthesis under the most stringent conditions bind to the template 3' of the other primers. Similarly, those primers which prime under the least stringent conditions bind to the template 5' of the other primers.
  • a first series of primer extension reactions (cycles) are carried out under the most stringent (highest temperature) primer annealing conditions, whereupon only the first set of primers participate in the synthesis of DNA containing the sequence of interest. Following a pre-selected number of primer extension cycles, the primer annealing conditions are made less stringent.
  • the second set of primers will initiate further DNA amplification by priming the linear copying of the second generation synthetic DNA produced during the first series of primer extension cycles under the selected conditions.
  • the third set of primers can participate in primer- dependent DNA synthesis, the second generation synthetic DNA' s produced in both the first and second series of primer extension reactions serve as templates for DNA replication.
  • the design of primers that bind at preselected temperatures is within the skill of molecular biologists.
  • the temperature at which a specific primer will function can be predicted by available algorithms ( ' v.'- ct al., DNA Cell Biol. 1 , 233-238 (1991)) and by computer programs (Rychlik et al . , Nucleic Acids Res. JL8, 6409-6412 (1990)) , based upon primer length and base composition.
  • Appropriate temperature cycling for in vitro DNA amplification can be performed manually or by commercially-available, programmable thermal cycler apparatus. Very fast cycle times can be achieved using hot air cyclers (Wittwer et al. , Nucleic Acids Res.
  • Appropriate temperature cycling which inactivates the reagent used to cleave first primer extension products can be incorporated into programs used with programmable thermal cycling apparatus for carrying out desired amplification reactions. For example, the activity of most RNases is destroyed by heating reaction mixtures containing RNase to 100.C for 3 to 5 minutes.
  • a primer is designed such that its 3' nucleotide is complementary to a particular nucleotide in the template known to be variable (polymorphic) .
  • the variable nucleotide can be a nucleotide involved in a genetic disease such as sickle cell anemia, or at another site known to be polymorphic. If a mismatch is present between the 3' nucleotide of the primer and the corresponding nucleotide of the template DNA, the primer design insures that it will be extended poorly, or, preferably, not at all. See Petruska et al. , PNAS USA J35., 6252-6256 (1 22) .
  • such a primer is "allele specific" and capable of discerning the presence of absence of a single base within a nucleic acid sequence of interest .
  • the presence of synthetic DNA following the use of an allele-specific primer in the process according to the present invention thus is indicative of the presence of the allele of interest in the original DNA template.
  • the primary products of the amplification process of the present invention are single-stranded synthetic DNA' s of a defined length.
  • the length of the product strand is determined by the position of the last-used primer and is equal to the sum of the length of the primer itself and the number of nucleotides which can be incorporated from the 3' end of the primer to the non-replicable element of the template.
  • the products can be detected by known nucleic acid detection techniques, including the use of primers or probes labelled with radioactivity, a fluorescent moiety or an enzyme, etc., electrophoresis, high pressure liquid chromatography, etc.
  • the present invention will have important application in the diagnosis of human and other animal genetic diseases .
  • Many human genetic diseases are known to be caused by specific changes in genes of known sequence.
  • DNA- based diagnosis is possible using hybridization or other allele specific technologies (see above) to determine which of the various gene sequences are present in the DNA of a person at risk for the disease (s) .
  • amplification of target DNA has been very helpful in developing these technologies.
  • the main advantages of template amplification are: smaller sample sizes can be used, the signal to noise ratio of the detection system is improved, there is a real potential for automation and the amplification system itself can be the detection system.
  • the processes of the present invention offer all of the same advantages offered by other amplification reactions, plus additional benefits.
  • the products are single stranded and thus do not have to be denatured prior to detection. If an odd number of primers is used, excess single stranded molecules will be produced. These molecules will be useful, for example, as hybridization probes, and thus provide an additional advantage over other amplification technologies. Still further advantages are presented as the products accumulate linearly and thus can be accurately quantified; the occurrence of "false positives" will be reduced in comparison with exponential processes that use newly-synthesized DNA as a template in subsequent rounds using the same primer. EXAMPLES Solutions utilized in several of the following examples are described below:
  • Tris-EDTA 10 mM Tris-HCl, 1 mM EDTA. pH 8.0 TBE (Tris-Borate-EDTA) : 89 mM Tris-HCl, 89 mM
  • Klenow polymerase Buffer 50 mM Tris-HCl, 10 mM MgCl 2 , pH 7.6
  • kinase Buffer 50 mM Tris-HCl, 10 mM MgCl 2 , 5 mM DTT, 0.1 mM spermidine-HCl, 0.1 mM EDTA, pH 7.6
  • DNA Polymerase I buffer 50 mM Tris-HCl, 10 mM MgS0 4 , 0.1 mM DTT, 50 ⁇ g/ml bovine serum albumin, pH 7.2
  • Sequenase buffer 40 mM Tris-HCl, 20 mM MgCl 2 , 50 mM NaCl, pH 7.5
  • Bst polymerase buffer 20 mM Tris-HCl, 20 mM MgCl 2 , pH 8.5
  • Thermus a ⁇ uaticus polymerase buffer 50 mM KCI, 10 mM Tris-HCl, 1.5 mM MgCl 2 , 0.01% w/v gelatin, pH 8.3
  • 10X Ficoll loading buffer 100 mM Tris-HCl pH 7.5, 10 mM EDTA, 0.5% bromophenol blue, 0.5% xylene cyanol, 30% Ficoll
  • 5X SSPE 50 mM sodium phosphate pH 7.0, 0.9 mM NaCl and 5 mM EDTA
  • Example 1 1,3 Propane Diol Blocks Primer Extension When Present in a Template
  • a template with or without a single nucleotide base containing a 1,3 propane diol moiety (designated as non-replicable element "X") and a primer complementary to the 3' end of the template were synthesized in order to demonstrate the ability of the 1,3 propane diol moiety to serve as a non-replicable element and halt DNA synthesis.
  • the sequences synthesized are ? follows:
  • primers and templates were annealed to form the following primer template complexes:
  • the primer template complexes were then extended with various DNA polymerases (Klenow fragment of DNA
  • the primer and templates were mixed at a primer/template ratio of 10, and buffers appropriate for the polymerase enzymes were employed. Twenty ⁇ l reactions containing 1 pmol of either 207 or 207-X, 10 pmol P12, 25 ⁇ M dNTPs, 0.5 ⁇ Ci of a- [ 32 P] -dCTP and either AmpliTaq buffer, BST buffer, Klenow buffer or Sequenase buffer. The samples were heated at 90°C for two minutes and cooled to 0°C for five minutes before adding one unit of DNA polymerase and reacting at 37°C for 10 minutes. The results indicate that the propane diol residue blocks primer elongation for all four DNA polymerases as shown below:
  • Diol-Containing Base Do Not Support PCR Four oligonucleotides were prepared, two of which contained the non-replicable 1,3-propane diol moiety. The sequences were synthesized on an Eppendorf Ecosyn D300 automated DNA synthesizer with the MMT-propane diol phosphoramidite in the Z position. When entering the sequence into the synthesizer, a Z was introduced. The sequences are presented in the following table:
  • BGP-2 22X GGGTGGGAAAATAGACCXATAG
  • BGP-1 30 GGCAGGAGCCAGGGCTGGGCATAAAAGTCA
  • the sites of complementarity of the oligonucleotides in the human j ⁇ -globin gene is shown in Figure 12.
  • I_n vitro amplification reactions were performed with various combinations of the four primers. Each reaction contained 100 ng of human genomic DNA, 6 pmol of each of two primers, in a standard PCR reaction buffer. Reactions were placed in a thermal cycler (Ericomp) and heated to 94°C for three minutes, cooled to 55°C for 30 seconds, heated to 72°C for 30 seconds and then subjected to 31 cycles of heating and cooling as follows: 94°C, one minute, 55°C, 30 seconds, 72°C for 30 seconds.
  • the plasmid pH/3 A was mixed with propane diol- containing primers (BGP-1 3OX and BGP-2 22X) or control primers (BGP-1 30 and BGP-2 22) not containing propane diol moieties.
  • the primer/template mixtures were subjected to thermal cycling conditions of 94°C for 20 seconds to dissociate the double-stranded template, followed by 48°C for 20 seconds. After the final cycle, the reaction mixtures were incubated a further 5 minutes 40 seconds at 48°C to complete the primer extension reaction and anneal the single stranded DNA's.
  • the reaction mixtures employing the propane diol-containing primers were cycled through 45 rounds of primer extension.
  • the PCR reactions utilizing the primers not containing propane diol moieties were cycled through 10 rounds of primer extension.
  • the products of the reactions were subjected to electrophoresis on 1.5% agarose (TBE buffer) .
  • the propane diol-containing primers produce a DNA fragment which was smaller than the PCR generated fragment. The smaller size is due to the fact that the primer extension does not extend to the end of the template strand, leaving 5' extensions on the product.
  • Figure ⁇ 1 presents a comparison of the products of a PCR reaction and of an LLA reaction according to the present invention.
  • the major products of a PCR reaction which accumulate exponentially, are completely double-stranded with defined ends corresponding to the ends of the primers employed.
  • the products of the present process are shorter than corresponding PCR products, as primer extension past the non-replicable element does not occur.
  • An amplification reaction according to the present invention was performed using BGP-1 3OX and BGP-2 22X for various numbers of cycles.
  • the products of the amplification were subjected to dot blot hybridization, and the hybridization signal was compared to that obtained from a known amount of plasmid DNA containing the sequence.
  • the products of the reactions (3 ⁇ l) were mixed with 10 ⁇ l 4N NaOH, 250 mM EDTA and were blotted onto a Zeta-Probe membrane (Bio-Rad Laboratories, Hercules, CA) . Also included on the membrane was 56, 118 and 231 ng of the plasmid pH/3 A similarly The membrane was hybridized with 5'- 32 P- CTGCAGTAACGGCAGACTTCTCCT at 55°C for three hours in 5X SSPE, 1% SDS, 5 mg/ml Blotto, 10 ⁇ g/ml Homomix I RNA. After hybridization the blot was washed at room temperature in 6X SSC and then scanned in a Bio-Rad Molecular Imager. The reaction produced approximately 250 fold amplification demonstrating the process of the present invention results in the amplification of the nucleic acid sequence of interest .
  • Example 5 Amplification Of The Human ⁇ -globin Gene From Genomic DNA Linear amplification reactions were performed according to the present invention in a 15 ⁇ l volume containing Thermus aquaticus polymerase buffer, template DNA (800 ng of genomic DNA or 10 4 molecules of plasmid pH/3 A ) , 200 ⁇ M each dNTP (dATP, dTTP, dCTP, and dGTP) , 2 pmol of oligonucleotide primers BGP5-22X and BGP4-22X, and 2 units of Ampli-Taq Polymerase (Perkin- Elmer Cetus) .
  • template DNA 800 ng of genomic DNA or 10 4 molecules of plasmid pH/3 A
  • dNTP dATP, dTTP, dCTP, and dGTP
  • 2 pmol of oligonucleotide primers BGP5-22X and BGP4-22X 2 units of Ampli-Taq Polymerase (Perkin- Elmer Cetus)
  • Plasmid pHj ⁇ A contains a 4.4 kb Pst I fragment of the human / ⁇ -globin gene cloned at the Pst I site of pBR322.
  • a negative control a reaction was carried out which included all the ingredients used in the previous reactions except the template DNA (a "no template” control) .
  • the amplification was performed for 99 cycles as follows: annealing at 55 °C for 30 sec, polymerization at 72 °C for 15 sec, and denaturation at 94 °C for 30 sec. At the end of the last cycle, the samples were annealed at 55 °C for 30 sec and finally polymerized at 72 °C for 4 min.
  • 7.5 ⁇ l were removed from each sample (genomic DNA, plasmid DNA, and negative control) , and mixed with 7.5 ⁇ l containing Thermus aguaticus polymerase buffer, 5 pmol of primers BGP1-35X and BGP2-35X, and 2 units of Ampli ⁇ Taq Polymerase.
  • the cycling program was similar to the program used in the first step, except that the annealing temperature was 63 °C.
  • One reaction contained Thermus aquaticus polymerase buffer, 5 pmol of primers BGP5-22X and BGP4-22X, 1 x IO 8 molecules of plasmid pH3 A , and 3 units of Ampli-Taq Polymerase.
  • the second control included the same ingredients as the previous reaction except that the primers BGP1-35X and BGP2-35X were used.
  • the template DNA was denatured for 4 min at 94 °C and then cycled 48 times using the following conditions program: annealing and polymerization at 55 °C for 30 sec; denaturation at 94 °C for 30 sec. At the end of the last cycle the samples were annealed at 55 °C for 30 sec and polymerized at 72 °C for 4 min.
  • the entire reaction (15 ⁇ l) was mixed with 1.6 ⁇ l 10X Ficoll loading buffer and subjected to electrophoresis in a 1.5% agarose gel (Bio-Rad ultrapure agarose) . Electrophoresis was performed in TBE buffer for 90 min at 110 volts. The gel was subsequently stained with ethidium bromide (1 ⁇ g/ml) for 30 .r*.i: ⁇ , destained for 15 min, and photographed by ultraviolet (UV) illumination. The electrophoresed DNA was then transferred to a nylon membrane (Zeta probe, Bio-Rad) by alkaline transfer (Reed, K. C. and D. A.
  • the "LLA" amplification reaction of the present invention was carried out in a 15 ⁇ l volume containing
  • Thermus aguaticus polymerase buffer 3.5 x IO 9 molecules of plasmid pHS A ) , 200 ⁇ M each dNTP
  • dATP dATP, TTP, dCTP, and dGTP
  • oligonucleotide primers BGP1-22X and BGP2-22X 5 picomoles of oligonucleotide primers BGP1-22X and BGP2-22X
  • Ampli-Taq DNA Polymerase Perkin-Elmer Cetus
  • the PCR reaction was performed for comparison purposes in a 15 ⁇ l volume containing Thermus aguaticus polymerase buffer, template DNA (3.5 x IO 9 molecules of plasmid pH/3 A ) , 200 ⁇ M each dNTP (dATP, TTP, dCTP, and dGTP) , 5 picomoles of oligonucleotide primers BGP1-22 and BGP2-22, and 1.25 units of Ampli-Taq DNA Polymerase. After denaturating the template DNA for 1 min, the amplification was performed for 9 cycles by annealing at 48 °C for 30 seconds and denaturing at 94 °C for 30 seconds. At the end of the last cycle, the samples were incubated at 48 °C for 4 min. Analysis of the LLA and PCR products
  • the membrane was hybridized in 5x SSPE, 1% sodium dodecyl sulfate (SDS) , 10 ⁇ g/ml homomix RNA, 0.5% powdered skim milk and 2.5 x IO 6 cpm of the 32 P labelled probe
  • Equal amounts of LLA (1/26 ⁇ l) and PCR (1/16 ⁇ l) products were diluted with distilled water by 10 4 , 10 s , and IO 6 fold; these dilutions were subsequently used as DNA templates in PCR reactions.
  • the amplification reactions were performed in a 15 ⁇ l volume containing Thermus aguaticus polymerase buffer, template DNA (LLA or PCR dilutions) , 200 ⁇ M each dNTP (dATP, TTP, dCTP and dGTP) , 5 picomoles of oligonucleotide primers BGP1-22 and BGP2-22, and 1 unit of Ampli-Taq Polymerase.
  • Reactions were duplicated and after a first step of thermal denaturation for 3 min at 94 °C, the samples were run for 25 and 30 cycles of amplification (30 seconds at 55 °C, 30 seconds at 72 °C, and 30 seconds at 94 °C) and finally incubated at 50 °C for 30 seconds and 4 min at 72 °C. Furthermore, a negative control which contained all reagents except the template DNA was included.
  • a second PCR reaction set was performed using a different primer set (MD040 and PC04) which prime internally to BGP1-22 and BGP2-22.
  • the reaction ingredients (except the primers) and reaction conditions were as described in the previous paragraph.
  • the 15 ⁇ l reaction volumes were mixed with 1.6 ⁇ l 10X Ficoll loading buffer and subjected to electrophoresis in a 1.5% agarose gel (Bio-Rad ultrapure agarose) . Electrophoresis was performed in lx TBE buffer for 90 min at 110 volts. The gel was subsequently stained with ethidium bromide (1 ⁇ g/ml) for 30 min, destained for 15 min, and photographed by ultraviolet (UV) illumination. The electrophoresed DNA wat. then transferred to a nylon membrane by alkaline transfer (Reed and Mann (1985) ) and fixed to the 5 membrane by UV radiation (Church (1984)) .
  • the membrane was prehybridized in 5X SSPE, 1% SDS, 10 ⁇ g/ml Homomix RNA and 0.5% dehydrated powdered skim milk for one hour and subsequently hybridized with 2.5 x 10 s cpm/ml of the 5'-P 32 labeled probe 5' CAGGAGTCAGGTGCACCATGGT for two
  • LLA reactions produce an amplicon which is very resistant to amplification from the outside primers and therefore will be resistant to the effects of carry over contamination.
  • SUBSTITUTESHEET(RULE2 ⁇ V prepared using standard automated solid-phase synthesis methods.
  • the uracil nucleoside in oligonucleotides GHl and GH2 are ribonucleosides.
  • In vitro amplification reactions were performed to amplify a fragment of the human growth hormone gene from genomic DNA samples using either ribonucleoside containing primers GHl and GH2 or deoxy-primers GH3 and GH4. Each reaction contained 500 ng of human genomic DNA, and 40 picomoles of each of two primers in a standard PCR reaction buffer which contained 1.5 units of Taq polymerase (Perkin-Elmer) .
  • the amplification reaction was carried out by placing the reaction mixtures into a thermal cycler, and heating to 95°C for 4 minutes, cooling to 52°C for 2 minutes, then heating to 72°C for 1 minute.
  • the amplification reaction was continued for 28 cycles as follows: 94°C for 4 minutes, 52°C for 2 minutes and 72°C for 1 minute; and then for one cycle as follows: 94°C for 1 minute, 52°C for 2 minutes and 72°C for 6 minutes.
  • amplified products were resolved on a 1.5% agarose gel, and then purified using "Prep-A-Gene" DNA purification kit (available from Bio-Rad.)
  • the amplified products in a reaction volume of 5.6 ⁇ l, were treated with 1.4 ⁇ l of 0.5 M NaOH to cleave the amplification products at the phosphodiester bond adjacent to the uracil ribonucleoside which had been incorporated into the first PCR product, then heated to 95°C for 15 minutes. These solutions were neutralized by adding 0.9 ⁇ l of 1M HCl, then the products were further linearly amplified to demonstrate that the first primer extension products "io ionger contained a complete copy of the ribonucleotide containing primer used in the PCR reaction.
  • the PCR products were primer extended using oligonucleotide Mdll4 which was labeled at its 5' end with P 32 .
  • Primer extension products made using PCR amplified fragment which had been treated with NaOH were shorter than primer extension products from PCR amplified fragments not cleaved with NaOH, depending on the primer used in the reaction.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La synthèse d'extension ('amplification') d'une séquence d'acides nucléiques est réalisée par une série liée de réactions d'extension d'amorces à cycles multiples (LLA). Les amorces utilisées dans chacune des réactions d'extension du processus contiennent des éléments non réplicables qui stoppent la synthèse des acides nucléiques et empêchent par conséquent les molécules synthétisées de servir de gabarit dans des cycles ultérieurs. Les molécules synthétisées s'accumulent de façon mathématiquement linéaire lors de l'extension des amorces, ce qui rend le processus relativement insensible aux acides nucléiques contaminants. Plusieurs groupes d'amorces sont utilisés, assurant ainsi l'accumulation d'un grand nombre de copies de la séquence d'acides nucléiques d'intérêt. L'invention se rapporte également à la détection d'une séquence d'acides nucléiques amplifiée ainsi qu'à des kits de réactifs permettant de faire intervenir la réaction.
EP96919362A 1995-06-07 1996-06-06 Amplification lineaire liee d'acides nucleiques Withdrawn EP0832278A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47560595A 1995-06-07 1995-06-07
US475605 1995-06-07
PCT/US1996/010059 WO1996040972A1 (fr) 1995-06-07 1996-06-06 Amplification lineaire liee d'acides nucleiques

Publications (2)

Publication Number Publication Date
EP0832278A1 true EP0832278A1 (fr) 1998-04-01
EP0832278A4 EP0832278A4 (fr) 1999-05-26

Family

ID=23888333

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96919362A Withdrawn EP0832278A4 (fr) 1995-06-07 1996-06-06 Amplification lineaire liee d'acides nucleiques

Country Status (5)

Country Link
EP (1) EP0832278A4 (fr)
JP (1) JPH11507235A (fr)
CN (1) CN1117871C (fr)
CA (1) CA2223527A1 (fr)
WO (1) WO1996040972A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802905C2 (de) * 1998-01-27 2001-11-08 Bruker Daltonik Gmbh Verfahren zur bevorzugten Herstellung nur eines Stranges selektierten Genmaterials für massenspektrometrische Messungen
US20160083724A1 (en) * 2014-09-24 2016-03-24 University Of Southern California Methods for sample preparation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0416817A2 (fr) * 1989-09-06 1991-03-13 Zeneca Limited Procédé d'amplification
WO1994021820A1 (fr) * 1993-03-17 1994-09-29 City Of Hope Sequences d'acides nucleiques presentant des extremites a un seul brin
WO1995003432A1 (fr) * 1993-07-23 1995-02-02 Bio-Rad Laboratories, Inc. Amplification lineaire enchainee d'acides nucleiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991011533A1 (fr) * 1990-01-26 1991-08-08 E.I. Du Pont De Nemours And Company Procede d'isolement de produits d'extension a partir de reactions de polymerase d'amorces d'adn orientees a l'aide d'un brin complementaire
US5426039A (en) * 1993-09-08 1995-06-20 Bio-Rad Laboratories, Inc. Direct molecular cloning of primer extended DNA containing an alkane diol

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0416817A2 (fr) * 1989-09-06 1991-03-13 Zeneca Limited Procédé d'amplification
WO1994021820A1 (fr) * 1993-03-17 1994-09-29 City Of Hope Sequences d'acides nucleiques presentant des extremites a un seul brin
WO1995003432A1 (fr) * 1993-07-23 1995-02-02 Bio-Rad Laboratories, Inc. Amplification lineaire enchainee d'acides nucleiques

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9640972A1 *

Also Published As

Publication number Publication date
CN1117871C (zh) 2003-08-13
CA2223527A1 (fr) 1996-12-19
WO1996040972A1 (fr) 1996-12-19
JPH11507235A (ja) 1999-06-29
CN1186520A (zh) 1998-07-01
EP0832278A4 (fr) 1999-05-26

Similar Documents

Publication Publication Date Title
US6027923A (en) Linked linear amplification of nucleic acids
US7501252B2 (en) Use of predetermined nucleotides having altered base pairing characteristics in the amplification of nucleic acid molecules
JP4289443B2 (ja) Ｐｃｒの過程でｄｎａ断片の増幅を抑制する方法
US20040091923A1 (en) Linked linear amplification of nucleic acids
AU647411B2 (en) Enhanced nucleic acid amplification process
EP0200362B1 (fr) Procédé pour l'amplification, la détection et/ou le clonage des séquences d'acide nucléique
US5554517A (en) Nucleic acid amplification process
US5624825A (en) Simultaneous amplification of multiple targets
WO1991002814A1 (fr) Procede d'amplification de sequences specifiques d'acide nucleique
JP2000505312A (ja) 標的核酸配列増幅
WO2003074724A2 (fr) Amplification polynomiale d'acides nucleiques
EP0854935B1 (fr) Procede de sequencage contigu de genome
WO1995003432A1 (fr) Amplification lineaire enchainee d'acides nucleiques
WO1993020096A1 (fr) Bibliotheques d'oligonucleotides utiles pour la production d'amorces
WO1999016904A1 (fr) Liaison efficace de segments d'acide nucleique
EP0227772B1 (fr) Production de sequence d'acide nucleique par inhibition d'exonuclease
US6335184B1 (en) Linked linear amplification of nucleic acids
WO1991004340A1 (fr) Amplification isothermique in vitro de l'acide nucleique
EP0832278A1 (fr) Amplification lineaire liee d'acides nucleiques
WO2000020630A1 (fr) Amorces oligonucleotidiques destabilisant la formation de duplex non specifiques et leurs utilisations
JPH0767646A (ja) 試料中に含まれる特定ｒｎａ配列を鋳型とする核酸配列の増幅方法
CA2346146A1 (fr) Amorces oligonucleotidiques destabilisant la formation de duplex non specifiques et leurs utilisations

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980105

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT

A4 Supplementary search report drawn up and despatched

Effective date: 19990413

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE FR GB IT

17Q First examination report despatched

Effective date: 20010123

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040217